{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:56:29Z","timestamp":1793534189088,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Treatment of head and neck squamous cell carcinomas (HNSCC) remains challenging with regards to radioresistance, particularly of Human Papilloma Virus (HPV)-negative tumors. Several new approaches are currently under pre-clinical and clinical investigation. Combination of radiotherapy (RT) and kinase inhibitors of the DNA damage repair system (DDRi), targeting Ataxia Telangiectasia Mutated (ATM) or ATM and Rad3-related (ATR), are promising, but the consequences on tumor cell phenotype are still scarce. We used AZD0156, an ATM inhibitor, and VE-822, an ATR inhibitor, in combination with normo-fractionated RT to treat two HPV-positive and two HPV-negative HNSCC cell lines. Generally, an effective reduction of clonogenicity was detected in tumor cells treated with a combination of RT\u2009+\u2009DDRi. Inhibiting ATM in combination with RT changed the cellular morphology, enhanced \u03b2-Gal activity and intensified secretion of senescence-associated cytokines. As senescent cells are naturally targeted by NK cells, we next analyzed the release of the cytokines IL-6 and IL-8 and found them to be differently regulated by the inhibitors. In co-culture with NK cells, an upregulation of activation markers on NK cells was observed, particularly after contact with RT\u2009+\u2009ATMi-treated HPV-negative HNSCC cells. We conclude that ATM inhibitor-related induction of senescence in HNSCC cells shapes the tumor micro-environment in way that NK cell phenotype is changed.<\/jats:p>","DOI":"10.1038\/s41598-025-17858-6","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:44:25Z","timestamp":1756446265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibiting the DNA damage repair of HNSCC cells in combination with normo-fractionated radiotherapy influences clonogenicity, senescence and expression of NK cell activation markers"],"prefix":"10.1038","volume":"15","author":[{"given":"Tina","family":"Jost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Meidenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo S.","family":"Gaipl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"1","key":"17858_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers. 6 (1), 92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"17858_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2217\/fon-2018-0405","volume":"15","author":"Y Yu","year":"2019","unstructured":"Yu, Y. & Lee, N. Y. JAVELIN head and neck 100: a phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer. Future Oncol. 15 (7), 687\u2013694. https:\/\/doi.org\/10.2217\/fon-2018-0405 (2019).","journal-title":"Future Oncol."},{"issue":"4","key":"17858_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","volume":"41","author":"KJ Harrington","year":"2023","unstructured":"Harrington, K. J. et al. Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study. J. Clin. Oncol. 41 (4), 790\u2013802. https:\/\/doi.org\/10.1200\/JCO.21.02508 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"17858_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00066-023-02064-y","volume":"199","author":"K Viktorsson","year":"2023","unstructured":"Viktorsson, K. et al. Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy. Strahlenther Onkol. 199 (12), 1091\u20131109. https:\/\/doi.org\/10.1007\/s00066-023-02064-y (2023).","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"17858_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang, R. X. & Zhou, P. K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal. Transduct. Target. Ther. 5 (1), 60. https:\/\/doi.org\/10.1038\/s41392-020-0150-x (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"17858_CR6","doi-asserted-by":"publisher","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144 (5). https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011). 646\u2009\u2013\u200974.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"17858_CR7","doi-asserted-by":"publisher","unstructured":"Bamps, M., Dok, R. & Nuyts, S. The DNA damage response is differentially involved in HPV-Positive and HPV-Negative radioresistant head and neck squamous cell carcinoma. Cancers (Basel). 13 (15). https:\/\/doi.org\/10.3390\/cancers13153717 (2021).","DOI":"10.3390\/cancers13153717"},{"issue":"12","key":"17858_CR8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00066-023-02103-8","volume":"199","author":"S Classen","year":"2023","unstructured":"Classen, S., Petersen, C. & Borgmann, K. Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors. Strahlenther Onkol. 199 (12), 1152\u20131163. https:\/\/doi.org\/10.1007\/s00066-023-02103-8 (2023).","journal-title":"Strahlenther Onkol"},{"key":"17858_CR9","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.neo.2023.100944","volume":"45","author":"F Grottker","year":"2023","unstructured":"Grottker, F. et al. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. Neoplasia 45, 100944. https:\/\/doi.org\/10.1016\/j.neo.2023.100944 (2023).","journal-title":"Neoplasia"},{"key":"17858_CR10","doi-asserted-by":"publisher","unstructured":"Shrivastava, N. et al. CDK4\/6 Inhibition induces senescence and enhances radiation response by disabling DNA damage repair in oral cavity squamous cell carcinoma. Cancers (Basel). 15 (7). https:\/\/doi.org\/10.3390\/cancers15072005 (2023).","DOI":"10.3390\/cancers15072005"},{"issue":"12","key":"17858_CR11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/s41419-021-04454-5","volume":"12","author":"U Schoetz","year":"2021","unstructured":"Schoetz, U. et al. Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. Cell. Death Dis. 12 (12), 1162. https:\/\/doi.org\/10.1038\/s41419-021-04454-5 (2021).","journal-title":"Cell. Death Dis."},{"key":"17858_CR12","doi-asserted-by":"publisher","first-page":"1192907","DOI":"10.3389\/fimmu.2023.1192907","volume":"14","author":"E Shin","year":"2023","unstructured":"Shin, E. et al. Understanding NK cell biology for Harnessing NK cell therapies: targeting cancer and beyond. Front. Immunol. 14, 1192907. https:\/\/doi.org\/10.3389\/fimmu.2023.1192907 (2023).","journal-title":"Front. Immunol."},{"key":"17858_CR13","doi-asserted-by":"publisher","unstructured":"Faulhaber, E. M. et al. Kinase inhibitors of DNA-PK, ATM and ATR in combination with ionizing radiation can increase tumor cell death in HNSCC cells while sparing normal tissue cells. Genes (Basel). 12 (6). https:\/\/doi.org\/10.3390\/genes12060925 (2021).","DOI":"10.3390\/genes12060925"},{"key":"17858_CR14","doi-asserted-by":"publisher","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari, R. & Jat, P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front. Cell. Dev. Biol. 9, 645593. https:\/\/doi.org\/10.3389\/fcell.2021.645593 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"17858_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118. https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102144 (2010).","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"17858_CR16","doi-asserted-by":"publisher","first-page":"188910","DOI":"10.1016\/j.bbcan.2023.188910","volume":"1878","author":"X Yu","year":"2023","unstructured":"Yu, X. et al. Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors. Biochim. Biophys. Acta Rev. Cancer. 1878 (4), 188910. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188910 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"17858_CR17","doi-asserted-by":"publisher","first-page":"1031944","DOI":"10.3389\/fonc.2022.1031944","volume":"12","author":"H Lei","year":"2022","unstructured":"Lei, H., He, A., Jiang, Y., Ruan, M. & Han, N. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. Front. Oncol. 12, 1031944. https:\/\/doi.org\/10.3389\/fonc.2022.1031944 (2022).","journal-title":"Front. Oncol."},{"issue":"9","key":"17858_CR18","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/stem.3391","volume":"39","author":"M Ruckert","year":"2021","unstructured":"Ruckert, M., Flohr, A. S., Hecht, M. & Gaipl, U. S. Radiotherapy and the immune system: more than just immune suppression. Stem Cells. 39 (9), 1155\u20131165. https:\/\/doi.org\/10.1002\/stem.3391 (2021).","journal-title":"Stem Cells"},{"key":"17858_CR19","doi-asserted-by":"publisher","unstructured":"Wimmer, S. et al. Hypofractionated radiotherapy upregulates several immune checkpoint molecules in head and neck squamous cell carcinoma cells independently of the HPV status while ICOS-L is upregulated only on HPV-Positive cells. Int. J. Mol. Sci. 22 (17). https:\/\/doi.org\/10.3390\/ijms22179114 (2021).","DOI":"10.3390\/ijms22179114"},{"key":"17858_CR20","doi-asserted-by":"publisher","first-page":"765968","DOI":"10.3389\/fonc.2022.765968","volume":"12","author":"S Kocher","year":"2022","unstructured":"Kocher, S. et al. A lack of effectiveness in the ATM-Orchestrated DNA damage response contributes to the DNA repair defect of HPV-Positive head and neck cancer cells. Front. Oncol. 12, 765968. https:\/\/doi.org\/10.3389\/fonc.2022.765968 (2022).","journal-title":"Front. Oncol."},{"key":"17858_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12979-020-00187-9","volume":"17","author":"A Kale","year":"2020","unstructured":"Kale, A., Sharma, A., Stolzing, A., Desprez, P. Y. & Campisi, J. Role of immune cells in the removal of deleterious senescent cells. Immun. Ageing. 17, 16. https:\/\/doi.org\/10.1186\/s12979-020-00187-9 (2020).","journal-title":"Immun. Ageing"},{"key":"17858_CR22","doi-asserted-by":"publisher","unstructured":"Zingoni, A. et al. Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance. Front Immunol, 8: p. 1194. (2017). https:\/\/doi.org\/10.3389\/fimmu.2017.01194","DOI":"10.3389\/fimmu.2017.01194"},{"issue":"6","key":"17858_CR23","doi-asserted-by":"publisher","first-page":"188994","DOI":"10.1016\/j.bbcan.2023.188994","volume":"1878","author":"T Saleh","year":"2023","unstructured":"Saleh, T., Bloukh, S., Hasan, M., Al, S. & Shboul Therapy-induced senescence as a component of tumor biology: evidence from clinical cancer. Biochim. Biophys. Acta Rev. Cancer. 1878 (6), 188994. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188994 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"17858_CR24","doi-asserted-by":"publisher","unstructured":"Dobler, C., Jost, T., Hecht, M., Fietkau, R. & Distel, L. Senescence induction by combined ionizing radiation and DNA damage response inhibitors in head and neck squamous cell carcinoma cells. Cells 9 (9). https:\/\/doi.org\/10.3390\/cells9092012 (2020).","DOI":"10.3390\/cells9092012"},{"issue":"2","key":"17858_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1158\/1535-7163.MCT-23-0794","volume":"24","author":"L Hayrapetyan","year":"2025","unstructured":"Hayrapetyan, L. et al. HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs Inhibition in combination with irradiation. Mol. Cancer Ther. 24 (2), 214\u2013229. https:\/\/doi.org\/10.1158\/1535-7163.MCT-23-0794 (2025).","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"17858_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/1541-7786.MCR-11-0134","volume":"10","author":"D White","year":"2012","unstructured":"White, D. et al. The ATM substrate KAP1 controls DNA repair in heterochromatin: regulation by HP1 proteins and Serine 473\/824 phosphorylation. Mol. Cancer Res. 10 (3), 401\u2013414. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0134 (2012).","journal-title":"Mol. Cancer Res."},{"key":"17858_CR27","doi-asserted-by":"publisher","unstructured":"Chen, W. T. et al. ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion. Elife 4. https:\/\/doi.org\/10.7554\/eLife.07270 (2015).","DOI":"10.7554\/eLife.07270"},{"issue":"38","key":"17858_CR28","doi-asserted-by":"publisher","first-page":"61820","DOI":"10.18632\/oncotarget.11445","volume":"7","author":"LP Chan","year":"2016","unstructured":"Chan, L. P. et al. IL-8 promotes HNSCC progression on CXCR1\/2-meidated NOD1\/RIP2 signaling pathway. Oncotarget 7 (38), 61820\u201361831. https:\/\/doi.org\/10.18632\/oncotarget.11445 (2016).","journal-title":"Oncotarget"},{"issue":"4","key":"17858_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-024-01417-0","volume":"32","author":"E Bournique","year":"2025","unstructured":"Bournique, E. et al. ATM and IRAK1 orchestrate two distinct mechanisms of NF-kappaB activation in response to DNA damage. Nat. Struct. Mol. Biol. 32 (4), 740\u2013755. https:\/\/doi.org\/10.1038\/s41594-024-01417-0 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"17858_CR30","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-kappaB signaling in inflammation. Signal. Transduct. Target. Ther. 2, 17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23 (2017).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"17858_CR31","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/cddis.2011.134","volume":"3","author":"MA Kang","year":"2012","unstructured":"Kang, M. A., So, E. Y., Simons, A. L., Spitz, D. R. & Ouchi, T. DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway. Cell. Death Dis. 3 (1), e249. https:\/\/doi.org\/10.1038\/cddis.2011.134 (2012).","journal-title":"Cell. Death Dis."},{"key":"17858_CR32","doi-asserted-by":"publisher","unstructured":"Akhter, N. et al. ROS\/TNF-alpha crosstalk triggers the expression of IL-8 and MCP-1 in human monocytic THP-1 cells via the NF-kappaB and ERK1\/2 mediated signaling. Int. J. Mol. Sci. 22 (19). https:\/\/doi.org\/10.3390\/ijms221910519 (2021).","DOI":"10.3390\/ijms221910519"},{"issue":"1","key":"17858_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 38 (1), 321. https:\/\/doi.org\/10.1186\/s13046-019-1310-0 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"17858_CR34","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1038\/s41596-021-00615-0","volume":"16","author":"N Brix","year":"2021","unstructured":"Brix, N., Samaga, D., Belka, C., Zitzelsberger, H. & Lauber, K. Analysis of clonogenic growth in vitro. Nat. Protoc. 16 (11), 4963\u20134991. https:\/\/doi.org\/10.1038\/s41596-021-00615-0 (2021).","journal-title":"Nat. Protoc."},{"issue":"2","key":"17858_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00066-021-01856-4","volume":"198","author":"H Wedekind","year":"2022","unstructured":"Wedekind, H. et al. Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages. Strahlenther Onkol. 198 (2), 171\u2013182. https:\/\/doi.org\/10.1007\/s00066-021-01856-4 (2022).","journal-title":"Strahlenther Onkol"},{"key":"17858_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3389\/fimmu.2020.01851","volume":"11","author":"J Kim","year":"2020","unstructured":"Kim, J. et al. A flow Cytometry-Based whole blood natural killer cell cytotoxicity assay using overnight cytokine activation. Front. Immunol. 11, 1851. https:\/\/doi.org\/10.3389\/fimmu.2020.01851 (2020).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17858-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17858-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:44:26Z","timestamp":1756446266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17858-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17858"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17858-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"16 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31827"}}